Диссертация (1146664), страница 22
Текст из файла (страница 22)
J., Davenport A. P. Emerging roles of apelin in biology andmedicine // Pharmacology and Therapeutics. – 2005. – Vol. 107. – P. 198–211.184. Knudson J. D., Dincer U. D., Zhang C., et al. Leptin receptors are expressedin coronary arteries, and hyperleptinemia causes significant coronaryendothelial dysfunction // Am. J. Physiol. Heart. Circ. Physiol. – 2005. – Vol.289. – P. 48–56.185. Kong Х. L., Jia X. Y., Wei Y.
et al. Association between microalbuminuriaand subclinical atherosclerosis evaluated by carotid artery intima-media inelderly patients with normal renal function // BMC Nephrology. – 2012. –Vol. 13:37.135186. Kotchen J. M., Kotchen T. A. Impact of female gormones on blood pressure:reviev of potential mechanisms and clinical studies // Curr. Hypertens.
Rep. –2003. – Vol. 5. – P. 505–512.187. Kunnari A., Ukkola O., Paivansalo M., Kesaniemi Y. A. High plasma resistinlevel is associated with enhanced highly sensitive C-reactive protein andleukocytes // J. of Clin. Endocrin. and Metab. – 2006. – Vol. 91. – P. 2755–2760.188. Lamarche B., Despres J. P., Moorjani M., et al. Prevalence of dyslipidemicphenotypes in ischemic heart disease (prospective results from the QuebecCardiovascular Study) // Am. J. Cardiol. – 1995.
– Vol. 75. – Р. 1189–1195.189. Lambeau, G., Gelb, M. H. Biochemistry and physiology of mammaliansecreted phospholipases A(2) // Annu. Rev. Biochem. – 2008. – Vol. 77. –P. 495–520.190. Lamers D., Famulla S. et al. Dipeptidyl peptidase 4 is a novel adipokinepotentially linking obesity to the metabolic syndrome // Diabetes. – 2011.
–Vol. 60 (7). – Р. 1917–1925.191. Laurer M., Anderson K., Kannel W., Levy D. The impact of obesity on leftventricle mass and geometry: the Framingham Heart Study // JAMA. – 1991. –Vol. 266. – P. 231–236.192. Leeper N. J., Tedesco M. M., Kojima Y. et al. Apelin prevents aorticaneurysm formation by inhibiting macrophage inflammation // Am.
J. Physiol.Heart. Circ. Physiol. – 2009. Vol. 296. – P. 1329–1335.193. Lehrke M., Becker A., Greif M. et al. Chemerin is associated with markers ofinflammation and components of the metabolic syndrome but does not predictcoronary atherosclerosis // European J. of Endocrinol. – 2009.
– Vol. 161. –P. 339–344.194. Levy D., Murabito J. M., Anderson K. M. Echocardiographic left ventricularhypertrophy – clinical characteristics – the Framinghan Heart Study // Clin.Exp. Hypertension. – 1992. – Vol. 14. – P. 85–97.136195. Levy D., Garrison R.J., Savage D.D. et al. Prognostic implications ofechocardiographically determined left ventricular mass in the Framinghamheart study. // N. Engl. J.
Med. 1990. - Vol. 322. - P. 1561-1566.196. Lewington S., Clarke R., Qizilbash N. et al. Age-specific relevance of usualblood pressure to vascular mortality: a meta-analysis of individual data for onemillion adults in 61 prospective studies // Lancet. – 2002. – Vol. 360. –P. 1903–1913.197. Lewis G. F., Rader D. J. New insights into the regulation of HDL metabolismand reverse cholesterol transport // Circ.
Res. – 2005. – Vol. 96. – P. 1221–1232198. Li J., Wu M., Que L. et al. Steroids. 17 beta-estradiol attenuates cardiacdysfunction and decreases NF-kappaB binding activity in mechanicallystretched rat hearts // Steroids. – 2008. – Vol. 73 (7). – P. 720–726.199. Lim S. Y., Davidson S. M., Paramanathan A. J. et al. The noveladipocytokine visfatin exerts direct cardioprotective effects // J. of Cellular andMolecular Medicine.
– 2008. – Vol. 12. – P. 1395–1403.200. Liu L., Wang Z. Estrogen attenuates lipopolysaccharide-induced nitric oxideproduction in macrophages partially via the nongenomic pathway // CellImmunol. – 2013. – Vol. 286 (1-2). – P. 53–58.201. Liu L., Zhao Y., Xie K. et al. Estrogen-Induced Nongenomic CalciumSignaling Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor aProduction in Macrophages // PLoS ONE. – 2013.
– Vol. 8 (12). – P. 83072.202. Maedler K., Schulthess F. T., Bielman C. et al. Glucose and leptin induceapoptosis in human b-cells and impair glucose-stimulated insulin secretionthrough activation of c-Jun N-terminal kinases // FASEB Journal. – 2008. –Vol. 22. – P. 1905–1913.203. Marvar P. J., Thabet S. R., Guzik T. J., et al.
Central and peripheralmechanisms of T-lymphocyte activation and vascular inflammation producedby angiotensin II−induced hypertension // Circ. Res. – 2010. – Vol. 107. –P. 263–270.137204. Masuraki H., Ogawa Y., Sagawa N. et al. Nonadipose tissue production ofleptin: leptin as a novel placenta-derived hormone in humans // Nat. Med. –1997. – Vol. 3. – P. 1029–1033.205. Marroquı L., Gonzalez A., Neco P. et al. Role of leptin in the pancreatic bcell: effects and signaling pathways // J.
of Mol. Endocrinol. – 2012. – Vol. 49.– P. 9–17.206. Mattu H. S., Randeva H. S. Role of adipokines in cardiovascular disease //J. Endocrinol. – 2013. –Vol. 216. – P 17–36.207. McFarlane S., Banerji M. Insulin resistance and cardiovascular disease //J. Clin. Endocrinol. Metab. – 2001. – Vol.
86 (22). – P. 713–718.208. McLarty J. L., Jianping Li., Levick S. P., Janicki J. S. Estrogen modulates theinfluence of cardiac inflammatory cells on function of cardiac fibroblasts // J.of Inflammation Research. – 2013. – Vol. 6. – P. 99–108.209. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and11-year risk of incident cardiovascular disease in the atherosclerosis risk incommunities study // Diabetes Care. – 2005 – Vol. 28. P. 385–390.210. Michalakis K., Mintziori G., Kaprara A.
et al. The complex interactionbetween obesity, metabolic syndrome and reproductive axis // Metabolism. –2013. – Vol. 62 (4). – P. 457–478.211. Milan G., Granzotto M., Scarda A. et al. Resistin and adiponectin expressionin visceral fat of obese rats: effect of weight loss // Obesity Research.
– 2002. –Vol. 10. – P. 1095–1103.212. Morioka T., Asilmaz E., Hu J. et al. Disruption of leptin receptor expressionin the pancreas directly affects b cell growth and function in mice // J. of Clin.Invest. – 2007. – Vol. 117. – P. 2860–2868.213. Morton N. M. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as acause and therapeutic target in metabolic disease // Mol. Cell. Endocrinol. –2010. – Vol. 316. – P. 154–164.138214. Moschen A. R., Kaser A., Enrich B. et al.
Visfatin, an adipocytokine withproinflammatory and immunomodulating properties // J. of Immunol. – 2007. –Vol. 178. – P. 1748–1758.215. Mu H., Ohashi R., Yan S. et al. Adipokine resistin promotes in vitroangiogenesis of human endothelial cells // Cardiovascular Research. – 2006. –Vol. 70. – P. 146–157.216. Naidoo D. P.
The link between microalbuminuria, endothelial dysfunctionand cardiovascular disease in diabetes // Cardiovasc. J. S. Afr. – 2002. – Vol.13 (4). – P. 194–199.217. Nakamura M., Onoda T., Itai K. et al. Association between serum C-reactiveprotein levels and microalbuminuria: a population-based cross-sectional studyin northern Iwate, Japan // Intern. Med.
– 2004. – Vol. 43 (10). – Р. 919–925.218. Nakanishi N., Kshiwakura Y. Nishina K. et al. Metabolic syndrome and riskof isolated ST-T abnormalities and type 2 diabetes in Japanese male officeworkers // Industr. Hlth. – 2005. – Vol. 43. – P. 269–276.219. Naseem K. M. The role of nitric oxide in cardiovascular diseases // Mol.Aspects Med. – 2005. – Vol. 26. – P. 33–65.220. Nicovani S., Rudolph M. I. Estrogen receptors in mast cells from arterialwalls // Biocell.
– 2002. – Vol. 26. – P. 15–24.221. Norata G. D., Ongari M., Garlaschelli K. et al. Plasma resistin levels correlatewith determinants of the metabolic syndrome // Eur. J. Endocrinol. – 2007. –Vol. 156. P. 279–284.222. Olefsky J. M., Glass C. K. Macrophages, inflammation, and insulin resistance// Annu. Rev. Physiol. – 2010.
– Vol. 72. – P. 219–246.223. Ouchi N., Kihara S., Arita Y. et al. Novel modulator for endothelial adhesionmolecules: adipocyte-derived plasma protein adiponectin // Circulation. –1999. – Vol. 100. – P. 2473–2476.224. Ouchi N., Kobayashi H., Kihara S. et al. Adiponectin stimulates angiogenesisby promoting crosstalk between AMP-activated protein kinase and Akt139signaling in endothelial cells // J. Biol. Chem. – 2004.
– Vol. 279. – P. 1304–1309.225. Ouchi N., Shibata R., Walsh K. Cardioprotection by adiponectin // Trends inCardiovascular Medicine. – 2006. – Vol. 16. – P. 141–146.226. Palomer X., Alvarez-Guardia D., Davidson M. M. et al. The interplaybetween NF-kappaB and E2F1 coordinately regulates inflammation andmetabolism in human cardiac cells // PLoS ONE. – 2011. – Vol. 6 (5). –P. 19724.227. Patel P., Khan N., Rani M., et al. The Expression of HIV-1 Vpu in MonocytesCauses Increased Secretion of TGF-β that Activates Profibrogenic Genes inHepatic Stellate Cells // PLoS One.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
